Von Willebrand factor levels in liver cirrhosis with portal hypertension
Part of Digestive system clinical trials.
This study looks at a protein called von Willebrand factor (VWF) in people with liver cirrhosis. It may help show how the disease affects bleeding risk and could guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- You can be male or female
- You must have a diagnosis of liver cirrhosis, whether or not you have symptoms (compensated or decompensated)
- You must not have acute liver disease, infections, sepsis, or other conditions that affect von Willebrand factor levels
- You must not have active cancers outside the liver, a previous liver transplant, or be taking medications that affect von Willebrand factor levels
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is following people with cirrhosis to see how often they get a blood clot in the liver's main vein (portal vein) and whether using blood thinners helps. If you have cirrhosis, joining this study could help doctors learn better ways to prevent and treat these clots.
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
This trial is for people with liver problems and high blood pressure in the veins of the liver (called portal hypertension). It will look at how the condition affects patients with and without cirrhosis (scarring of the liver).
This study tests a new, painless ultrasound method to check for high blood pressure in the liver's main blood vessel. It aims to avoid more invasive tests for people with cirrhosis. It might help doctors tell if you are at risk of bleeding without a catheter procedure.
This study uses a simple ultrasound-based test (FibroScan) to check liver stiffness and predict whether you have high pressure in the veins around the liver. It aims to see if a new set of criteria can safely tell who needs an endoscopy, helping avoid unnecessary procedures.
This study looks at special cells from blood vessels (endothelial colony-forming cells) in people with von Willebrand disease (a bleeding disorder) or a related acquired condition. The goal is to better understand these conditions using blood donations.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.